Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Expert Review of Anticancer Therapy|May 1, 2015
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunityAndrea Ravelli, James M Reuben, Francesco Lanza, et al.
Leukemia Research|June 28, 2005
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Leukemia & Lymphoma|June 3, 2017
Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myelomaGiuseppe Milone, Massimo Martino, Salvatore Leotta, et al.
Tumori|November 11, 2003
Differences in transplant-related complications between hematologic malignancies and solid tumors receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantationMassimo Martino, Fortunato Morabito, Giuseppe Console, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2019
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline UpdateJulia Bohlius, Kari Bohlke, Roberto Castelli, et al.
Hematology Reports|November 25, 2024
Treatment Strategies Used in Treating Myelofibrosis: State of the ArtMassimo Martino, Martina Pitea, Annalisa Sgarlata, et al.
Transplantation and Cellular Therapy|March 30, 2021
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective StudyBeatrice Anna Zannetti, Francesco Saraceni, Claudia Cellini, et al.
Blood Advances|April 12, 2019
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline updateJulia Bohlius, Kari Bohlke, Roberto Castelli, et al.
Expert Opinion on Pharmacotherapy|November 19, 2019
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphomaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
Cytotherapy|July 20, 2015
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patientsMassimo Martino, Anna Grazia Recchia, Tiziana Moscato, et al.
Pageof 17